Stock Analysis

3 Growth Companies With High Insider Ownership On KRX Expecting Up To 99% Earnings Growth

KOSE:A003230
Source: Shutterstock

The South Korean market has remained flat over the past year, with the Healthcare sector gaining 5.6% in the last week and overall earnings forecasted to grow by 29% annually. In this environment, growth companies with high insider ownership can be particularly appealing as they often signal strong internal confidence and potential for substantial earnings growth.

Top 10 Growth Companies With High Insider Ownership In South Korea

NameInsider OwnershipEarnings Growth
People & Technology (KOSDAQ:A137400)16.4%35.6%
Seojin SystemLtd (KOSDAQ:A178320)30.5%52.1%
Bioneer (KOSDAQ:A064550)15.8%97.6%
Oscotec (KOSDAQ:A039200)26.3%122%
ALTEOGEN (KOSDAQ:A196170)26.6%99.5%
Park Systems (KOSDAQ:A140860)33%35.7%
Vuno (KOSDAQ:A338220)19.5%110.9%
HANA Micron (KOSDAQ:A067310)18.3%100.3%
UTI (KOSDAQ:A179900)33.1%134.6%
Techwing (KOSDAQ:A089030)18.7%83.6%

Click here to see the full list of 88 stocks from our Fast Growing KRX Companies With High Insider Ownership screener.

Let's explore several standout options from the results in the screener.

ALTEOGEN (KOSDAQ:A196170)

Simply Wall St Growth Rating: ★★★★★★

Overview: ALTEOGEN Inc., a biotechnology company, specializes in developing long-acting biobetters, proprietary antibody-drug conjugates, and antibody biosimilars with a market cap of ₩18.59 billion.

Operations: Revenue from biotechnology amounts to ₩90.79 million.

Insider Ownership: 26.6%

Earnings Growth Forecast: 99.5% p.a.

ALTEOGEN Inc. recently received approval from the Ministry of Food and Drug Safety for Tergase®, a recombinant hyaluronidase with over 99% purity, marking its transition to a commercial-stage company. The stock trades at 72.7% below estimated fair value, with earnings forecasted to grow 99.46% annually and revenue expected to increase by 64.2% per year, significantly outpacing market averages. Additionally, ALTEOGEN is projected to achieve high return on equity (66.3%) within three years while becoming profitable during the same period.

KOSDAQ:A196170 Earnings and Revenue Growth as at Sep 2024
KOSDAQ:A196170 Earnings and Revenue Growth as at Sep 2024

Samyang Foods (KOSE:A003230)

Simply Wall St Growth Rating: ★★★★☆☆

Overview: Samyang Foods Co., Ltd., along with its subsidiaries, operates in the food industry both in South Korea and internationally, with a market cap of ₩4.01 trillion.

Operations: Samyang Foods generates revenue from its food business operations in South Korea and international markets.

Insider Ownership: 11.6%

Earnings Growth Forecast: 21.5% p.a.

Samyang Foods is forecasted to achieve a high return on equity of 30.3% in three years, with earnings expected to grow significantly at 21.45% annually, though slightly below the market's average growth rate. Revenue is projected to rise by 18.2% per year, outpacing the overall South Korean market's growth of 10.4%. Despite trading at 61.7% below its estimated fair value, there has been no substantial insider trading activity recently.

KOSE:A003230 Earnings and Revenue Growth as at Sep 2024
KOSE:A003230 Earnings and Revenue Growth as at Sep 2024

Hyosung Heavy Industries (KOSE:A298040)

Simply Wall St Growth Rating: ★★★★☆☆

Overview: Hyosung Heavy Industries Corporation manufactures and sells heavy electrical equipment in South Korea and internationally, with a market cap of ₩3.16 trillion.

Operations: The company's revenue segments include ₩1.78 billion from Construction and ₩3.35 billion from Heavy Industry.

Insider Ownership: 16.4%

Earnings Growth Forecast: 35.3% p.a.

Hyosung Heavy Industries is expected to achieve significant annual earnings growth of 35.3%, outpacing the South Korean market's 29%. Despite a forecasted revenue growth of 10.3% per year, slightly below the market average, the company has seen earnings grow by 117.9% over the past year. Analysts predict a stock price rise of 24.9%, and it trades at 59% below its estimated fair value, although debt coverage remains an issue and share price volatility is high.

KOSE:A298040 Earnings and Revenue Growth as at Sep 2024
KOSE:A298040 Earnings and Revenue Growth as at Sep 2024

Next Steps

Curious About Other Options?

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.The analysis only considers stock directly held by insiders. It does not include indirectly owned stock through other vehicles such as corporate and/or trust entities. All forecast revenue and earnings growth rates quoted are in terms of annualised (per annum) growth rates over 1-3 years.

New: Manage All Your Stock Portfolios in One Place

We've created the ultimate portfolio companion for stock investors, and it's free.

• Connect an unlimited number of Portfolios and see your total in one currency
• Be alerted to new Warning Signs or Risks via email or mobile
• Track the Fair Value of your stocks

Try a Demo Portfolio for Free

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com